| [1] |
Zou R, Xie W, Wang H, et al. Establishment and application of a method for high-risk human papillomavirus genotyping in cervical cancer tissue[J]. Clin Lab, 2016, 62(6): 1075-1085.
|
| [2] |
Tezcan S, Ozgur D, Ulger M, et al. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings[J]. Asian Pac J Cancer Prev, 2014, 15(9): 3997-4003.
|
| [3] |
Liu Y, Zhang C, Gao W, et al. Genome-wide profiling of the human papillomavirus DNA integration in cervical intraepithelial neoplasia and normal cervical epithelium by HPV capture technology[J]. Sci Rep, 2016, 6: 35427.
|
| [4] |
Wardak S. Human Papillomavirus (HPV) and cervical cancer[J]. Med Dosw Mikrobiol, 2016, 68(1): 73-84.
|
| [5] |
Li H, Wang X, Geng J, et al. Clinical study of styping detection of human papillomavirus (HPV) infection with microarray from paraffinembedded specimens of cervical cancer and precursor lesions[J]. J Nanosci Nanotechnol, 2015, 15(9): 6423-6428.
|
| [6] |
Bosch FX, Burchell AN, Schiffman M, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia[J]. Vaccine, 2008, 26(Suppl 10): K1-K16.
|
| [7] |
Benevolo M, Donà MG, Ravenda PS, et al. Anal human papillomavirus infection: prevalence, diagnosis and treatment of related lesions[J]. Expert Rev Anti Infect Ther, 2016, 14(5): 465-477.
|
| [8] |
Jiménez-Wences H, Peralta-Zaragoza O, Fernández-Tilapa G. Human papilloma virus, DNA methylation and microRNA expression in cervical cancer (review)[J]. Oncol Rep, 2014, 31(6): 2467.
|
| [9] |
Katki HA, Cheung LC, Fetterman B, et al. A joint model of persistent human papillomavirus infection and cervical cancer risk: implications for cervical cancer screening[J]. J R Stat Soc Ser A Stat Soc, 2015, 178(4): 903-923.
|
| [10] |
Einstein MH, Burk RD. Persistent human papillomavirus infection: definitions and clinical implications[J]. Papillomavirus Rep, 2001, 12(5): 119-123.
|
| [11] |
Gravitt PE, Rositch AF. HPV self-testing and cervical cancer screening coverage[J]. Lancet Oncol, 2014, 15(2): 128-129.
|
| [12] |
Castle PE, Schiffman M, Wheeler CM, et al. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3[J]. Cancer Epidemiol Biomarkers Prev, 2010, 19(7): 1675-1681.
|
| [13] |
Asgary S, Sabbagh S, Eghbal MJ. Published endodontic articles in PubMed-Indexed journals from Iran[J]. Iran Endod J, 2012, 7(1): 1-4.
|
| [14] |
Massad LS, Einstein MH, Huh WK, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors[J]. Obstet Gynecol, 2013, 121(4): 829-846.
|
| [15] |
Ryu A, Nam K, Kwak J, et al. Early human papillomavirus testing predicts residual/recurrent disease after LEEP[J]. J Gynecol Oncol, 2012, 23(4): 217-225.
|
| [16] |
缪飞，王秀丽，王宏伟，等. 5-氨基酮戊酸光动力治疗宫颈高危型HPV感染[J]. 中国皮肤性病学杂志，2012, 26(1): 49-50.
|
| [17] |
陈晓静，叶菁. 阴道局部干扰素应用对宫颈高危型人乳头瘤病毒感染进程影响的临床研究[J]. 实用妇产科杂志，2016, 32(6): 450-452.
|
| [18] |
宣秀芳. 派特灵治疗宫颈HPV高危感染的临床观察[J]. 浙江实用医学，2014, 19(3): 202-203.
|
| [19] |
刘小莉. 保妇康栓治疗HPV感染疗效观察[J]. 山西中医，2015, 31(11): 53.
|
| [20] |
杨莉. 冷冻联合保妇康栓治疗慢性宫颈炎伴HPV感染的疗效分析[J]. 江苏医药，2016, 42(1): 82-83.
|
| [21] |
Schiffman M, Wentzensen N. From human papillomavirus to cervical cancer[J]. Obstet Gynecol, 2010, 116(1): 177-185.
|
| [22] |
Schiffman M, Castal PE, Jeronimo J, et al. Human papillomavirus and cervical cancer[J]. Lancet, 2007, 370(9590): 890-907.
|
| [23] |
Mayeaux EJ Jr, Cox JT. 现代阴道镜学. 魏丽惠，赵昀，译. 3版[M]. 北京：北京大学医学出版社，2016: 445-455.
|